Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 10Pancreatic Neoplasms 9Neoplasm Metastasis 5Breast Neoplasms 5Melanoma 4Colorectal Neoplasms 4Prostatic Neoplasms 3Ovarian Neoplasms 3Lymphoma 3Lung Neoplasms 3Liver Neoplasms 3Carcinoma, Renal Cell 3Wilms Tumor 2Urinary Bladder Neoplasms 2Stomach Neoplasms 2Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Neuroblastoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Kidney Neoplasms 2Astrocytoma 2Adenomatous Polyposis Coli 2Thyroid Neoplasms 1Thrombocytosis 1Somatostatinoma 1Sarcoma, Clear Cell 1Retinoblastoma 1

Interventions

Temozolomide 3Capecitabine 3Trastuzumab 2Bevacizumab 2veliparib 1tipifarnib 1temsirolimus 1Sunitinib 1Specimen Handling 1Sirolimus 1Panobinostat 1Oxaliplatin 1Nivolumab 1Melphalan 1Magnetic Resonance Spectroscopy 1Leucovorin 1Ipilimumab 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunoglobulin G 1Floxuridine 1Fentanyl 1Disulfides 1CTLA-4 Antigen 1Bortezomib 111-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Somatostatinoma × Sirolimus × Gastrointestinal × Clear all
NCT01010126 2019-01-25

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

National Cancer Institute (NCI)

Phase 2 Completed
252 enrolled 20 charts
GastrointestinalGynecologic

Fallopian Tube Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Somatostatinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡